| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |